Back to RIGL
MARSHALL WACE, LLP RIGL Position History
Rigel Pharmaceuticals, Inc.
Quarters held
8
Latest value
$329K
Q2 2026
Peak value
$15.1M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $228K |
| Q3 2023 | $39K |
| Q1 2024 | $649K |
| Q1 2026 | $1.1M |
| Q1 2026 | $15.1M |
| Q2 2026 | $864K |
| Q2 2026 | $13.2M |
| Q2 2026 | $329K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $329K | 8.4K | — | — |
| Q2 2026 | $13.2M | 336.9K | — | — |
| Q2 2026 | $864K | 22.1K | — | — |
| Q1 2026 | $15.1M | 556.6K | — | — |
| Q1 2026 | $1.1M | 41.8K | — | — |
| Q1 2024 | $649K | 438.6K | — | — |
| Q3 2023 | $39K | 36.0K | — | — |
| Q1 2023 | $228K | 172.7K | — | — |
Other funds holding RIGL
$40.7M
$40.7M
$30.3M
$22.4M
$22.4M
$13.8M
$12.9M